Covid and Schizophrenia: Why This Deadly Mix Can Deepen Knowledge of the Brain Disease
Recent studies from around the world have found that people with schizophrenia are as much as five times as likely to die from covid-19 as the general population. Scientists think the findings suggest schizophrenia is not just a disease of the brain, but also a disease of the immune system.
Journalists Recap Coverage of the Ongoing Pandemic and Lead Risks in Schools’ Drinking Water
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Watch: Omicron Subvariant Is Nothing to Sneeze At, Explains KHN’s Public Health Expert
A KHN public health expert discusses the new covid subvariant, seasonal allergies, and the debate over whether Americans will need a fourth vaccination.
KHN’s ‘What the Health?’: The ACA Turns 12
Although its fate was in doubt more than a few times, the Affordable Care Act turned 12 this week. Year 13 could be pivotal in determining how many Americans receive ACA health insurance, and at what price. Meanwhile, three leading credit bureaus agreed to stop using most medical debt to measure U.S. consumers’ creditworthiness. Anna Edney of Bloomberg News, Rachel Cohrs of Stat, and KHN’s Mary Agnes Carey join KHN’s Julie Rovner to discuss these issues and more.
El futuro en la vigilancia de enfermedades infecciosas puede estar… en el popó
El lodo que se recolecta de las aguas residuales, adonde se arrojan las heces de la comunidad, puede ser clave para detectar no solo covid, sino otras enfermedades infecciosas.
Health Officials See Bright Future in Poop Surveillance
Sewage surveillance is proving so useful in mapping covid trends that many public health officials say it should become standard practice in tracking infectious diseases. Whether that happens will depend on the nation’s ability to make it viable in communities rich and poor.
Patients With Vulnerable Immune Systems Worry Vaccine Exemptions May Put Them in Peril
Montana’s governor pushed the state’s health workers to seek religious exemptions to a federal mandate to be vaccinated against covid, but the number who have done so is unknown.
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
Sharing Covid Vax Facts Inside ICE Detention, One Detainee at a Time
Thousands of ICE detainees nationwide have tested positive for covid; 11 have died. Medical providers in California are volunteering to educate immigrants awaiting trial or deportation about covid treatment and vaccination.
Médicos voluntarios comparten información sobre las vacunas de covid con detenidos de ICE
Los detenidos dicen que confían en ellos. Doctores hablan por teléfono con personas en centros del ICE y ofrecen información confiable sobre las vacunas.
KHN’s ‘What the Health?’: We May Be Done With Covid, But Covid’s Not Done With Us
The White House makes a move as a new wave of covid threatens. President Joe Biden brings in Dr. Ashish Jha to take over the executive branch effort. Meanwhile, it remains unclear if and when Congress can come up with the funds to continue much of the federal anti-covid effort. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sandhya Raman of CQ Roll Call, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more.
It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.
Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
Readers and Tweeters Remain Vigilant on Masking and Billing
KHN gives readers a chance to comment on a recent batch of stories.
Listen: What We’ve Learned After Two Years of the Pandemic
KHN Editor-in-Chief Dr. Elisabeth Rosenthal joins the CNN podcast “Reliable Sources” and reflects on the societal trauma that covid-19 has wrought.
Pandemic Medical Innovations Leave Behind People With Disabilities
As the country enters Year 3 of the pandemic emergency, people with disabilities across the U.S. are still finding it difficult to use innovations in telemedicine, teleworking, and testing.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’
Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.
One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?
The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.
The CDC’s New Guidelines on Covid Risk and Masking Send Confounding Signals
The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.
